Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2022 Publisher: Neon Healthcare Ltd., 8 The Chase, John Tate Road, Hertford, SG13 7NN, United Kingdom
Potassium para-aminobenzoate 3 g powder is indicated for the treatment of Peyronie’s disease and scleroderma in adults.
One sachet containing 3 g Potassium para-aminobenzoate powder should be taken orally, four times daily.
The safety of Potassium para-aminobenzoate 3 g powder in children aged 0 to 18 years has not been established. No data are available.
For oral use.
The contents of one sachet should be dissolved in cold water or fruit juice and taken orally with food.
No particular problems are expected following overdose with Potassium para- aminobenzoate 3 g powder. Symptomatic and supportive therapy should be given as appropriate.
5 years.
Do not store above 25°C.
Store in the original packaging.
Cardboard outer containing 40 foil laminate sachets.
Any unused product or waste material should be disposed of in accordance with local requirements.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
